IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Investors and academics have long sought for a way to compare the performance of portfolios on a risk-adjusted basis. If you can adjust for risk, you can directly compare the performance of portfolios ...
Short answer: There are countless ways we could measure risk-taking in the brain. But one paradigm I find particularly elegant is known as the Balloon Analogue Risk Task (BART). The Balloon Analogue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback